rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

J. Jay Lobell

Director

Company insider

Files Form 4 as: Director, Fortress Biotech; Director, Pardes Biosciences; CEO and Secretary, Chem Rx; Director, CytRx Oncology; Director, Novadel Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
97
Buys
5
Sells
0
Bought
$540K
Sold
$0
Companies
5
Companies where not an officer
4
First trade
11 Jan 2006
Last trade
1 Jan 2026
Last filed
5 Jan 2026

Companies traded

Where they are an officer
Chem RxDirector, Officer · last 16 Jan 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
FBIO Fortress BiotechDirector · Biotechnology · last 1 Jan 20264 buys · 0 sells
Pardes BiosciencesDirector · last 31 Aug 20230 buys · 0 sells
CytRx OncologyDirector · last 19 Sep 20080 buys · 0 sells
Novadel PharmaDirector · last 8 Sep 20081 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jan 2026filed 5 Jan 2026FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—27,322 at $0.00filing
1 Jan 2026filed 5 Jan 2026FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—27,322 at $0.00filing
1 Jan 2025filed 3 Jan 2025FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—49,383 at $0.00filing
1 Jan 2024filed 3 Jan 2024FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—6,666 at $0.00filing
31 Aug 2023filed 31 Aug 2023Pardes Biosciencesoption or derivativeSEC FORM 4 Code D—37,500filing
31 Aug 2023filed 31 Aug 2023Pardes Biosciencesoption or derivativeSEC FORM 4 Code D—75,000filing
31 Aug 2023filed 31 Aug 2023Pardes Biosciencesoption or derivativeSEC FORM 4 Code D—37,500filing
31 Aug 2023filed 31 Aug 2023Pardes BiosciencesSEC FORM 4 Code U—200,000filing
31 Aug 2023filed 31 Aug 2023Pardes BiosciencesSEC FORM 4 Code U—1,163,861filing
1 Jun 2023filed 2 Jun 2023Pardes Biosciencesoption or derivativeSEC FORM 4 Code A—37,500 at $0.00filing
10 Feb 2023filed 14 Feb 2023FBIO Fortress BiotechBiotechnologySEC FORM 4 Bought$251K299,401 at $0.84filing
1 Jan 2023filed 4 Jan 2023FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
19 Jul 2022filed 21 Jul 2022Pardes BiosciencesSEC FORM 4 Code J—3,591,265 at $0.00filing
19 Jul 2022filed 21 Jul 2022Pardes BiosciencesSEC FORM 4 Code J—200,000 at $0.00filing
19 Jul 2022filed 21 Jul 2022Pardes BiosciencesSEC FORM 4 Code J—1,163,861 at $0.00filing
8 Jun 2022filed 10 Jun 2022Pardes Biosciencesoption or derivativeSEC FORM 4 Code A—37,500 at $0.00filing
1 Jan 2022filed 29 Apr 2022FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
23 Dec 2021filed 28 Dec 2021Pardes Biosciencesoption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
1 Jan 2021filed 9 Apr 2021FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
1 Jan 2020filed 13 Mar 2020FBIO Fortress BiotechBiotechnologySEC FORM 4 Code A—100,000 at $0.00filing

Sectors

Health Care4
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.